Dr. Frederick M. Briccetti, MD

Dr. Briccetti practices at Concord Hospital in Hooksett, New Hampshire.

Dr. Briccetti's NPI, 1063406932, was assigned on September 7, 2005. Dr. Briccetti graduated from University Of Cincinnati College Of Medicine in 1988. Dr. Briccetti's New Hampshire license number on file is 9146.

Dr. Briccetti's primary practice is Concord Hospital, at 11 Kimball Dr, Hooksett, NH 03106 in Merrimack County. The practice phone is (603) 227-7000.

Dr. Briccetti's primary practice is Concord Hospital in Hooksett, New Hampshire. The medical group on file is New Hampshire Oncology-Hematology, PA.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Briccetti practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Briccetti's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Briccetti's licenses on file in 2 states: New Hampshire and Massachusetts.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Briccetti treats.

CMS data shows 39,005 Medicare services from Dr. Briccetti across 31 procedure codes in 2023. Medicare paid $861,150 for them.

Across all payers, Dmand AI patient panel data puts Dr. Briccetti's median patient age at 77, with 50% women.

In 2024, Dr. Briccetti wrote 132 Medicare Part D claims for 52 patients. 95% of them were for generic drugs. CMS names the drug for 79 of them, across 4 drugs with 11 or more claims each, at $68,431 in total drug cost. In 2023, CMS named 401 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Briccetti for performance year 2024, reported as part of a group.

Dmand AI links 9 papers to Dr. Briccetti, published from 2008 to 2022. 2021 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Paclitaxel. Dr. Briccetti has published most often in J Clin Oncol. Dr. Briccetti's most frequent co-authors are Ann H. Partridge, MD, MPH, Sara Michell Tolaney, MD and Caroline C. Block, MD.

Dmand AI links Dr. Briccetti to 26 clinical trials, 13 of them phase 3 studies. 12 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Non-Small-Cell Lung and Rectal Diseases. Alliance for Clinical Trials in Oncology sponsors the most, 8. Open Payments lists research payments to Dr. Briccetti that name 1 trial.

CMS Open Payments shows 10 general payments to Dr. Briccetti from 8 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 69% of the total. Pharmacyclics LLC, An AbbVie Company paid the most, $92. It also lists 1 research payment totaling $319 in 2022, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Briccetti, most recently CMS Stage 1 EHR in 2014.

Dr. Briccetti graduated from University Of Cincinnati College Of Medicine in 1988. Dr. Briccetti is a member of ASCO.

Dr. Briccetti is in network with 11 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.